Compare Edwards Lifesciences Corporation Common Stock (EW) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs ProShares UltraPro QQQ ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while ProShares UltraPro QQQ ETF trades at $81.94 (market cap $38.74B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | TQQQ | |
|---|---|---|
Market Cap | $48.56B | $38.74B |
Volume | 6,520,488 | 65,384,797 |
Sector | Health | Leveraged / Inverse |
52-Week High | $95.18 | $87.22 |
52-Week Low | $72.65 | $37.89 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TQQQ trades at $83.60, down 0.77% on the day, with technical indicators showing a bullish moving average signal but overbought RSI conditions. The leveraged ETF structure amplifies both gains and losses, with recent news highlighting hidden costs beyond the stated 0.82% expense ratio. Support levels cluster around $81-82, while resistance sits at $84-86.
The outlook remains tied to Nasdaq-100 performance, with AI-driven tech earnings providing potential catalysts. However, volatility decay and amplified downside risk during market corrections present significant challenges for long-term holders. Institutional activity shows mixed positioning with recent stake reductions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
